Canada Life
SRNE

Canada Life’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Canada Life’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,202
Closed -$23K – 2347
2022
Q4 		$23K Buy
26,202
+7,536
+40% +$10K ﹤0.01% 2234
2022
Q3 		$29K Buy
18,666
+680
+4% +$1.54K ﹤0.01% 2193
2022
Q2 		$36K Buy
17,986
+675
+4% +$1.17K ﹤0.01% 2124
2022
Q1 		$42K Buy
17,311
+696
+4% +$2.17K ﹤0.01% 2198
2021
Q4 		$77K Buy
16,615
+651
+4% +$4.04K ﹤0.01% 2071
2021
Q3 		$123K Hold
15,964
– – ﹤0.01% 2009
2021
Q2 		$154K Buy
15,964
+26
+0.2% +$207 ﹤0.01% 1993
2021
Q1 		$131K Hold
15,938
– – ﹤0.01% 2043
2020
Q4 		$108K Buy
15,938
+8,755
+122% +$70.3K ﹤0.01% 2097
2020
Q3 		$80K Hold
7,183
– – ﹤0.01% 2086
2020
Q2 		$45K Buy
+7,183
New +$27.5K ﹤0.01% 2251
2019
Q4 		– Sell
-5,186
Closed -$11K – 2784
2019
Q3 		$11K Sell
5,186
-4,588
-47% -$10.7K ﹤0.01% 1099
2019
Q2 		$25K Hold
9,774
– – ﹤0.01% 2564
2019
Q1 		$46K Hold
9,774
– – ﹤0.01% 2274
2018
Q4 		$23K Hold
9,774
– – ﹤0.01% 2526
2018
Q3 		$43K Hold
9,774
– – ﹤0.01% 2426
2018
Q2 		$69K Buy
+9,774
New +$66.5K ﹤0.01% 2326
2017
Q2 		– Sell
-5,200
Closed -$20K – 2552
2017
Q1 		$20K Hold
5,200
– – ﹤0.01% 2461
2016
Q4 		$26K Buy
+5,200
New +$31.2K ﹤0.01% 2457

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Canada Life's SRNE Position: Q1 2023 in Review

Canada Life sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 26,202 shares — an estimated $23K sold.

Canada Life first reported a position in SRNE in Q4 2016 and held it in 19 quarters. The position peaked at $154K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Canada Life reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Canada Life sold 26,202 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $23K.
  • Canada Life first reported a position in Sorrento Therapeutics, Inc. in Q4 2016 and held it in 19 quarters.
  • Canada Life's Sorrento Therapeutics, Inc. position peaked at $154K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Canada Life's 13F filing for Q1 2023, filed 12 May 2023.